Life sciences and medical device companies are dealing with an unprecedented crisis. The industry is not only managing the impact of Coronavirus (COVID-19), they are also a solution provider. Companies are rapidly adapting...more
4/14/2020
/ CARES Act ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Creditors ,
Crisis Management ,
Exports ,
Federal Funding ,
Financial Solvency ,
Food and Drug Administration (FDA) ,
Government Assistance ,
Imports ,
Life Sciences ,
Manufacturers ,
Medical Devices ,
Recessions ,
Research and Development ,
Restructuring ,
Supply Chain ,
Vendors ,
Webinars
Because the lasting impact and full scope of COVID-19 remains largely unknown, companies must be prepared to deal with any challenges that may arise, particularly those that could result in unforeseen financial distress. We...more
Following the recent outbreak of the coronavirus (COVID-19), companies are becoming increasingly concerned about the related financial and commercial implications, including problematic supply chain disruption, workforce...more